Turnstone Biologics Corp. (TSBX) Dividend History

Turnstone Biologics Corp. is a biotechnology company focused on developing innovative oncolytic virus immunotherapies for cancer treatment. The company utilizes a proprietary platform to create personalized and targeted therapies aimed at stimulating the immune system to fight tumors effectively. Based in Canada, Turnstone Biologics emphasizes the advancement of its pipeline through clinical development and collaborations in the immuno-oncology space.

9310 Athena Circle, Suite 300, La Jolla, CA, 92037
Phone: 347-897-5988
Website: https://www.turnstonebio.com

Dividend History

Turnstone Biologics Corp. currently does not pay dividends

Company News

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

GlobeNewswire Inc.
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights

Turnstone reports fourth quarter and full year 2023 financial results and provides recent business highlights.

GlobeNewswire Inc.
Turnstone Biologics to Participate in Upcoming Investor Conferences

Turnstone to present and participate in TD Cowen 44th Annual Global Health Care Conference and Leerink Partners Global Biopharma Conference 2024.

GlobeNewswire Inc.
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.

Turnstone announced with sadness that the Company's Chief Legal Officer passed away following prolonged battle with cancer.

GlobeNewswire Inc.
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

Dr. Sammy Farah, President and CEO of Turnstone, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference in New York.

GlobeNewswire Inc.

Dividend data last updated 06/08/2025 00:09:49 UTC